This company listing is no longer active
LXG.H Stock Overview
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
LexaGene Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.10 |
| 52 Week High | CA$0.30 |
| 52 Week Low | CA$0.065 |
| Beta | 2.25 |
| 1 Month Change | 0% |
| 3 Month Change | -19.23% |
| 1 Year Change | -43.24% |
| 3 Year Change | -87.20% |
| 5 Year Change | -91.60% |
| Change since IPO | -58.00% |
Recent News & Updates
Recent updates
It's Unlikely That LexaGene Holdings Inc.'s (CVE:LXG) CEO Will See A Huge Pay Rise This Year
Feb 02
We're A Little Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Rate
Oct 07Here's Why We're Not Too Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Situation
May 17We Think LexaGene Holdings (CVE:LXG) Can Afford To Drive Business Growth
Feb 01Shareholder Returns
| LXG.H | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | 1.2% | 1.2% |
| 1Y | -43.2% | -25.5% | 6.1% |
Return vs Industry: LXG.H underperformed the Canadian Medical Equipment industry which returned -1% over the past year.
Return vs Market: LXG.H underperformed the Canadian Market which returned -2.4% over the past year.
Price Volatility
| LXG.H volatility | |
|---|---|
| LXG.H Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 11.5% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: LXG.H's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine LXG.H's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 33 | Jack Regan | www.lexagene.com |
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets; and assay panels. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.
LexaGene Holdings Inc. Fundamentals Summary
| LXG.H fundamental statistics | |
|---|---|
| Market cap | CA$14.78m |
| Earnings (TTM) | -CA$11.53m |
| Revenue (TTM) | CA$140.83k |
104.9x
P/S Ratio-1.3x
P/E RatioIs LXG.H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LXG.H income statement (TTM) | |
|---|---|
| Revenue | US$104.27k |
| Cost of Revenue | US$757.46k |
| Gross Profit | -US$653.19k |
| Other Expenses | US$7.89m |
| Earnings | -US$8.54m |
Last Reported Earnings
Nov 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.061 |
| Gross Margin | -626.46% |
| Net Profit Margin | -8,189.91% |
| Debt/Equity Ratio | 66.4% |
How did LXG.H perform over the long term?
See historical performance and comparison